SU385436A1 - - Google Patents
Info
- Publication number
- SU385436A1 SU385436A1 SU1619741A SU1619741A SU385436A1 SU 385436 A1 SU385436 A1 SU 385436A1 SU 1619741 A SU1619741 A SU 1619741A SU 1619741 A SU1619741 A SU 1619741A SU 385436 A1 SU385436 A1 SU 385436A1
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- insulin
- hours
- acid
- desphenylalanine
- mmol
- Prior art date
Links
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Substances N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 22
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 12
- 102000004877 Insulin Human genes 0.000 description 10
- 108090001061 Insulin Proteins 0.000 description 10
- 229940125396 insulin Drugs 0.000 description 10
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 8
- 108700022976 B-insulin Proteins 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 6
- 241000282887 Suidae Species 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- QKFJKGMPGYROCL-UHFFFAOYSA-N phenyl isothiocyanate Chemical compound S=C=NC1=CC=CC=C1 QKFJKGMPGYROCL-UHFFFAOYSA-N 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241000283690 Bos taurus Species 0.000 description 3
- 101000993800 Sus scrofa Insulin Proteins 0.000 description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 101001011741 Bos taurus Insulin Proteins 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 239000012062 aqueous buffer Substances 0.000 description 2
- IXIBAKNTJSCKJM-BUBXBXGNSA-N bovine insulin Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3NC=NC=3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)C(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 IXIBAKNTJSCKJM-BUBXBXGNSA-N 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- -1 for example Substances 0.000 description 2
- 150000002540 isothiocyanates Chemical class 0.000 description 2
- 229940117953 phenylisothiocyanate Drugs 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- MZZVFXMTZTVUFO-UHFFFAOYSA-N 1-chloro-4-isothiocyanatobenzene Chemical compound ClC1=CC=C(N=C=S)C=C1 MZZVFXMTZTVUFO-UHFFFAOYSA-N 0.000 description 1
- NOESYZHRGYRDHS-ZYCCASTOSA-N 8a-l-threonine-10a-l-isoleucine-insulin Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3NC=NC=3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 NOESYZHRGYRDHS-ZYCCASTOSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- 108010005991 Pork Regular Insulin Proteins 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- ZMZINYUKVRMNTG-UHFFFAOYSA-N acetic acid;formic acid Chemical compound OC=O.CC(O)=O ZMZINYUKVRMNTG-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- UDSAIICHUKSCKT-UHFFFAOYSA-N bromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2S(=O)(=O)O1 UDSAIICHUKSCKT-UHFFFAOYSA-N 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- LGUHADBEXWHGIZ-UHFFFAOYSA-N butyl n-diazocarbamate Chemical compound CCCCOC(=O)N=[N+]=[N-] LGUHADBEXWHGIZ-UHFFFAOYSA-N 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- CUPFNGOKRMWUOO-UHFFFAOYSA-N hydron;difluoride Chemical compound F.F CUPFNGOKRMWUOO-UHFFFAOYSA-N 0.000 description 1
- 239000004026 insulin derivative Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19702005658 DE2005658C (de) | 1970-02-07 | Verfahren zur Herstellung von Des-Phenylalanin hoch B 1-Insulin |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SU385436A1 true SU385436A1 (2) | |
| SU385436A3 SU385436A3 (2) | 1973-05-29 |
Family
ID=5761705
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SU1619741A SU385436A3 (2) | 1970-02-07 | 1971-02-03 |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US3801564A (2) |
| JP (1) | JPS5136276B1 (2) |
| AT (1) | AT308293B (2) |
| BE (1) | BE762575A (2) |
| BG (1) | BG17979A3 (2) |
| CA (1) | CA945143A (2) |
| CH (1) | CH569700A5 (2) |
| CS (1) | CS155966B2 (2) |
| DK (1) | DK139577C (2) |
| EG (1) | EG10440A (2) |
| ES (1) | ES387934A1 (2) |
| FI (1) | FI53304C (2) |
| FR (1) | FR2104735B1 (2) |
| GB (1) | GB1340924A (2) |
| IE (1) | IE34934B1 (2) |
| IL (1) | IL36124A (2) |
| NL (1) | NL168502C (2) |
| NO (1) | NO133590C (2) |
| PL (1) | PL81164B1 (2) |
| RO (1) | RO58860A (2) |
| SE (1) | SE370935B (2) |
| SU (1) | SU385436A3 (2) |
| YU (1) | YU34786B (2) |
| ZA (1) | ZA71673B (2) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2256215C3 (de) * | 1972-11-16 | 1981-01-08 | Hoechst Ag, 6000 Frankfurt | Insulin-Zubereitung mit einem Gehalt an kristallinem Insulin und amorphem Desphenylalanin8' -insulin |
| DE3333640A1 (de) * | 1983-09-17 | 1985-04-25 | Hoechst Ag, 6230 Frankfurt | Verfahren zur herstellung von insulin-derivaten, deren b-kette c-terminal verlaengert ist, neue basisch modifizierte insulin-derivate diese enthaltende mittel und ihre verwendung |
-
1971
- 1971-02-01 EG EG49/71A patent/EG10440A/xx active
- 1971-02-02 IL IL36124A patent/IL36124A/xx unknown
- 1971-02-02 NL NLAANVRAGE7101360,A patent/NL168502C/xx not_active IP Right Cessation
- 1971-02-03 ZA ZA710673A patent/ZA71673B/xx unknown
- 1971-02-03 SU SU1619741A patent/SU385436A3/ru active
- 1971-02-04 ES ES387934A patent/ES387934A1/es not_active Expired
- 1971-02-04 YU YU256/71A patent/YU34786B/xx unknown
- 1971-02-04 CH CH166371A patent/CH569700A5/xx not_active IP Right Cessation
- 1971-02-05 NO NO440/71A patent/NO133590C/no unknown
- 1971-02-05 BE BE762575A patent/BE762575A/xx not_active IP Right Cessation
- 1971-02-05 AT AT99271A patent/AT308293B/de not_active IP Right Cessation
- 1971-02-05 CS CS87271*#A patent/CS155966B2/cs unknown
- 1971-02-05 US US00113097A patent/US3801564A/en not_active Expired - Lifetime
- 1971-02-05 CA CA104,546A patent/CA945143A/en not_active Expired
- 1971-02-05 SE SE7101434A patent/SE370935B/xx unknown
- 1971-02-05 DK DK53071A patent/DK139577C/da active
- 1971-02-05 FR FR7103898A patent/FR2104735B1/fr not_active Expired
- 1971-02-05 IE IE137/71A patent/IE34934B1/xx unknown
- 1971-02-05 FI FI310/71A patent/FI53304C/fi active
- 1971-02-06 PL PL1971146070A patent/PL81164B1/pl unknown
- 1971-02-06 BG BG016760A patent/BG17979A3/xx unknown
- 1971-02-08 RO RO65848A patent/RO58860A/ro unknown
- 1971-02-08 JP JP46005174A patent/JPS5136276B1/ja active Pending
- 1971-04-19 GB GB2126071A patent/GB1340924A/en not_active Expired
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69813158T2 (de) | Assays zur Bestimmung von Proteinfragmenten in biologischen Medien | |
| Drewett et al. | The family of guanylyl cyclase receptors and their ligands | |
| Bergel et al. | Cyto-active amino-acid and peptide derivatives. Part I. Substituted phenylalanines | |
| Kemp et al. | Parathyroid hormone-related protein of malignancy: active synthetic fragments | |
| JP4519324B2 (ja) | 共有結合で架橋されたインスリンダイマー | |
| TW201837051A (zh) | 包含藥物動力學增強劑之經修飾之鬆弛素(relaxin)多肽及其用途 | |
| RU2176646C2 (ru) | Инсулин и его производные с повышенной способностью связывать цинк | |
| TWI811220B (zh) | 結合聚集蛋白聚糖之免疫球蛋白 | |
| Flik et al. | Cellular calcium transport in fish: unique and universal mechanisms | |
| PL175955B1 (pl) | Wektor ekspresyjny, szczep E. coli transformowany tym wektorem oraz sposób produkcji apolipoproteiny Ai-M (Milano) | |
| RS50378B (sr) | N-heterociklični derivati kao nos inhibitori | |
| KR20180005249A (ko) | 병리학적 석회화 병태를 치료하기 위한 조성물, 및 이의 사용 방법 | |
| Schofield et al. | Procollagen-a precursor form of collagen | |
| JP2024073641A (ja) | Ｃ型ナトリウム利尿ペプチド移植抗体 | |
| SU385436A1 (2) | ||
| DK149778B (da) | Analogifremgangsmaade til fremstilling af des-pheb1-humaninsulin eller derivater deraf | |
| WO1996002267A1 (en) | Peptide, a method of obtaining it and a pharmaceutical compound based on it | |
| Wallner et al. | Lab scale and medium scale production of recombinant allergens in Escherichia coli | |
| TW202012437A (zh) | 腦利尿鈉肽植入抗體 | |
| PL167810B1 (pl) | Sposób enzymatycznej hydrolizy lancucha aminokwasu przedproinsuliny PL PL | |
| JP4084411B2 (ja) | 組換え型イヌ胃リパーゼ及び医薬組成物 | |
| EA010860B1 (ru) | Антиинфарктные молекулы | |
| Karsner et al. | A NOTE ON THE IMMEDIATE EFFECTS OF REDUCTION OF KIDNEY SUBSTANCES | |
| JP2006510342A (ja) | プロトロンビン活性化タンパク質 | |
| Weber | Isolation of glycocyamine from urine |